NO
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
64.868
Exchange
OOTC - OTC
369.4 B
Last period Assets ,DKK
213%
Assets has increased in 5 years
What is Assets ?
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
See also Novo Nordisk
Company Analysis
NONOF valuation, rating, competitors, insights and company profile
Eyestock Rating
NONOF financial analysis by Eyestock methodology
Valuation
NONOF valuation using historical relative method
Statements
NONOF Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NONOF dividend yield and annual dividend
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
Novo Nordisk`s Assets for the period ended 2024-06-30 are 369.4 B DKK
